Clinical Trials Directory

Trials / Completed

CompletedNCT04155775

Effects of a Platelet Transfusion Best Practices Alert

Status
Completed
Phase
N/A
Study type
Interventional
Enrollment
446 (actual)
Sponsor
Stanford University · Academic / Other
Sex
All
Age
Healthy volunteers
Not accepted

Summary

This study is to determine the effectiveness of a computerized clinical decision support tool (Best Practice Alert - BPA) in reducing unnecessary platelet transfusions based on guidelines published by national transfusion societies such as the AABB (formerly American Association of Blood Banks).

Detailed description

A computerized alert will be deployed through the electronic health record. The alert will trigger when a provider orders platelet transfusion above a threshold supported by current guidelines. The alert will provide information on current evidence and give the provider the option to cancel the order or proceed. The alert will not be triggered in procedural areas such as the operating room or as part of any emergency orders to prevent any delays to urgent patient care. The proposed project will evaluate this alert by randomizing its implementation by patient chart. The investigators will observe the prevalence of this alert and its impact on ordering practices for the next 3 months. For patient charts randomized not to receive the intervention, the providers will not receive any alerts, but the analytics tool will record if the alert would have been triggered and the pertinent clinical information. After a period of three months, the investigators will review patient and provider information through analytics tools, assessing differences in platelet usage between the patients whose charts showed the alerts vs. those (control) patient charts not showing alerts.

Conditions

Interventions

TypeNameDescription
OTHERComputer electronic health record alert (Best Practice Alert - BPA)Upon ordering platelets in patients with recent platelet count \>50,000, a pop-up within the electronic health system will recommend to not continue with transfuse product order and provide clinical exceptions to continue. Importantly, the alert does not trigger in operating areas, emergency medicine treatment areas, for certain specialties like neurosurgery or for massive transfusion orders.

Timeline

Start date
2019-05-09
Primary completion
2020-02-04
Completion
2020-02-04
First posted
2019-11-07
Last updated
2023-02-09

Locations

1 site across 1 country: United States

Source: ClinicalTrials.gov record NCT04155775. Inclusion in this directory is not an endorsement.